Veradigm Issued Patent for Risk Adjustment Method and Apparatus

Veradigm is providing health plans with a patent-protected method to support risk adjustment programs through “Dynamic Intervention Planning”

CHICAGO--(BUSINESS WIRE)-- Veradigm, a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), today announced that its method and apparatus for risk adjustment patent (“Dynamic Intervention Planning”) has been issued by the United States Patent and Trademark Office (USPTO).

The patent covers the systems that power Veradigm’s Dynamic Intervention Planning process. These systems enable Veradigm’s clients to find, size, monetize, prioritize, and resolve opportunities across different lines of business.

“Dynamic Intervention Planning can result in a greater risk adjustment lift for our clients. It allows our clients to properly focus their efforts to be more impactful,” says Tom Langan, President and Chief Commercial Officer of Veradigm. “This means less waste, greater precision in revenue projections, and more control over how our clients manage their programs.”

Through this patent, only Veradigm can identify service item management opportunities, ascribe levels of confidence, and size Risk Adjustment Factor points. This Veradigm Network solution can also recommend and prioritize interventions, communicate opportunities for action electronically to external devices, and dynamically update all of this as the health plan member’s data builds and refines over time.

About Veradigm®

Veradigm is a healthcare technology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. Some healthcare technology companies deliver clinical data for biopharma and health plans, some help turn that data into insights, others serve healthcare providers directly by providing point-of-care clinical software and patient outreach platforms, Veradigm does all of these and more. The Veradigm Network features a dynamic community of solutions and partners providing advanced insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

For more information on Veradigm, visit www.veradigm.com, or find Veradigm on LinkedIn, Facebook, Twitter, and YouTube.

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2022 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220629005232/en/

Investors:

Jenny Gelinas

312-506-1237

Jenny.Gelinas@allscripts.com

Media:

Amanda Cohen

412-919-2417

Amanda.Cohen@veradigm.com

Source: Allscripts Healthcare Solutions

FAQ

What is the Dynamic Intervention Planning patent by Veradigm?

The Dynamic Intervention Planning patent provides a system to enhance risk adjustment programs, allowing clients to identify and prioritize opportunities effectively.

How does the Dynamic Intervention Planning benefit health plans?

It enables health plans to improve precision in revenue projections and manage programs more effectively, potentially leading to increased financial returns.

When was the Dynamic Intervention Planning patent issued?

The patent was issued by the United States Patent and Trademark Office as announced in the recent press release.

What company is behind Veradigm and its recent patent?

Veradigm is a business unit of Allscripts Healthcare Solutions, which trades under the ticker symbol MDRX.